Biogen Idec (Nasdaq: BIIB) has agreed to acquire Stromedix Inc., a Cambridge, Mass.-based biotech company focused on therapies for fibrosis and organ failure. The deal is valued at up to $562.5 million, including a $75 million upfront cash payment. Stromedix previously raised around $38 million in VC funding from Atlas Venture, Frazier Healthcare Ventures, Bessemer Venture Partners, Red Abbey Venture Partners and New Leaf Venture Partners. www.stromedix.com
Garmin Ltd. (Nasdaq: GRMN) has agreed to acquire Interphase Technologies Inc., a Soquel, Calif.-based developer of phased array scanning sonar technologies. No financial terms were disclosed. www.interphase-tech.com
Glory Ltd. has offered to acquire British cash handling equipment maker Talaris from The Carlyle Group at an enterprise value of £650 million. www.carlyle.com
IK Investment has hired Morgan Stanley to manage the sale of German industrial weighing company Schenck Process, according to Reuters. IK paid approximately €450 million to buy the company from HgCapital in 2007. www.schenckprocess.com
Goldman Sachs has sold its remaining 3.9% stake in South Korean bank Hana Financial Group for $331 million (3% discount to yesterday’s closing price), according to Bloomberg. www.gs.com
Xstrata (LSE: XTA) is looking to sell up to 20% in a proposed $6.4 billion Australian coal project, according to the WSJ. Macquarie Capital is handling the process. Xtrata recently agreed to merge with fellow mining company Glencore International (LSE: GLEN). www.xstrata.com
Want deal news in your inbox each morning? Then get Term Sheet!
